Navigation Links
The American Parkinson Disease Association Awards $1.5 Million in Research Grants
Date:8/16/2017

With a new PD diagnosis every nine minutes, research is critical as we push for better treatments and ultimately, a cure.

The grants are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board (SAB) which is comprised of scientists with a wide array of backgrounds and expertise in all areas relevant to PD research. The SAB meets annually to review all grant proposals and set the scientific direction of APDA’s annual research investment. Their focus is to identify researchers early in their careers and attract them to the PD field, as well as to help established investigators pursue new and novel ideas. In many cases these projects produce significant pilot data, which has enabled researchers to apply for and receive multimillion dollar research grants from the National Institutes of Health and other funding institutions.

“There is an urgent need to accelerate research and support translational ideas that have the potential to truly improve the quality of life for people living with PD,” commented David G. Standaert, MD, PhD, John N. Whitaker Professor, Chair of Neurology at the University of Alabama at Birmingham, School of Medicine and Chairman of the SAB. “Now is a time of tremendous excitement in Parkinson’s research. The objective of the SAB is to invest in the best science that will move the field forward, to slow or cure the disease.”

APDA has been a funding partner in many of the significant Parkinson’s scientific discoveries in the last 50 years including the work of Dr. George C. Cotzias, which led to establishing the effectiveness of levodopa in treating PD; this treatment remains the gold standard in PD treatment today.

“The work being done as a result of the grants in this new funding cycle will have an incredible impact on the world of PD,” stated Leslie A. Chambers, President & CEO of APDA. “We are truly excited about the range of projects we are able to support - from neuroprotection that can slow the progress of the disease, to biomarkers which can help measure the activity of the disease, to novel ideas such as wearables and evidence-based non-medical therapies that can help improve quality of life. The questions posed by our researchers span a broad and exciting range of areas. This work is only possible because of the steadfast support of our generous APDA donors.”

Post-Doctoral Fellowships were awarded to support post-doctoral scientists whose research holds promise to provide new insights into pathophysiology, etiology and treatment of PD:

  • Xu Hou, PhD, Mayo Clinic, Jacksonville, FL
  • Md Shariful Islam, PhD, Van Andel Institute, Grand Rapids, MI
  • Isabel Lam, PhD, The Brigham and Women’s Hospital, Boston, MA
  • An Phu Tran Nguyen, PhD, Van Andel Institute, Grand Rapids, MI

Research Grants were awarded to investigators affiliated with and performing PD research at major academic institutions across the United States.

  • Joseph DeGutis, PhD, and Alice Cronin-Golomb, PhD, Boston University School of Medicine, Boston, MA
  • Xianjun Dong, PhD, The Brigham and Women’s Hospital, Boston, MA
  • Michael L. Gross, PhD, Washington University School of Medicine, St. Louis, MO
  • Andreas H. Kottmann, PhD, City College of New York, New York City, NY
  • Beom-Chan Lee, PhD, University of Houston, Houston, TX
  • Xiaobo Mao, PhD, Johns Hopkins University School of Medicine, Baltimore, MD
  • Ignacio F. Mata, PhD, Seattle Institute for Biomedical and Clinical Research, Seattle, WA
  • Rahul Srinivasan, PhD, Texas A&M Health Science Center, Bryan, TX
  • Yulan Xiong, PhD, Kansas State University, Manhattan, KS
  • Talene Yacoubian, MD, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL
  • Tonya Zeczycki, PhD, East Carolina University, Greenville, NC

APDA Centers for Advanced Research support large research programs which include research trainees, fellowship programs, early stage discovery programs and later stage clinical translation. These Centers facilitate research which is at the forefront of investigation into the cause, treatment and ultimately cure for PD.

  • Boston University School of Medicine, Boston, MA
  • David Geffen School of Medicine at UCLA Medicine, Los Angeles, CA
  • Emory University School of Medicine, Atlanta, GA
  • Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
  • University of Alabama at Birmingham, School of Medicine, Birmingham, AL
  • University of Pittsburgh Medical Center, PA
  • University of Virginia Health System, Charlottesville, VA
  • Washington University School of Medicine, St. Louis, MO

Learn more about these grantees and the exciting work they are doing and browse all APDA funded research.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14604605.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Florida Hospital and the American Heart Association Inspire Women to Share Their Stories on Heart Disease and Stroke
2. American Psychiatric Nurses Association Welcomes Members to Board of Directors and 2018 Nominating Committee
3. CareDx Describes Extensive Analytical Validation Data on AlloSure Robustness at American Association of Clinical Chemistry Annual Meeting
4. As Lifestyle Medicine Continues to Emerge As Medicine’s Fastest Growing Field, Hundreds Register For First-Ever American Board Of Lifestyle Medicine Certification Exam
5. Author David Johnson’s Newly Released “Jim Kersting: An American Dream” Is the Story of Achieving the American Dream from the Humble Beginnings of a Midwestern Farm Boy
6. Distinguished Dentist in Denville, NJ, Dr. Adam Kimowitz, Becomes Diplomate of the American Board of Oral Implantology/Implant Dentistry
7. American Farmer Proudly Announces Syngenta Participation in Upcoming Episode
8. North American Veterinary Heart Center Sets the Global Standard for Dog and Cat Cardiac Surgery
9. Therachat to Exhibit at the 125th American Psychological Association Annual Convention
10. Discovering Advances in Animal Health Technology on American Farmer
11. Lifestyle Medicine Institute Takes Seat as Newest Founding Member of the American College of Lifestyle Medicine Corporate Roundtable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... PurhealthRX , a leading Health and Nutrition Company, is announcing the ... spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the amount ... into liquid products, while reducing costs to end users. , The team of researchers ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)...  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided ... Piedras, Puerto Rico , where the ... Following a comprehensive onsite ... structural damage, temporary loss of power and minimal water ... manufacturing operations have resumed, and the company expects to ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
Breaking Medicine Technology: